ENABLE: The First Phase 4 Observational Study for Patients with Relapsing MS Treated with Ublituximab in Real World Clinical Setting (P7-1.014)

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211909
Citations
1
Primary Topic
Polyomavirus and related diseases
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ENABLE: The First Phase 4 Observational Study for Patients with Relapsing MS Treated with Ublituximab in Real World Clinical Setting (P7-1.014)

Hari P. Miskin, Jackie Parker, Karthik Bodhinathan, Carrie M. Hersh et al.
1 citations
Neurology
Polyomavirus and related diseases
1.05
article

ENABLE: The First Phase 4 Observational Study for Patients with Relapsing MS Treated with Ublituximab in Real World Clinical Setting (P7-1.014)

Hari P. Miskin, Jackie Parker, Karthik Bodhinathan, Carrie M. Hersh, Peter Sportelli, Edward Fox
article en
1 citations

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
Cleveland Clinic (US), Lou Ruvo Brain Institute (US), CDG Therapeutics (United States) (US)
Openalex Percentile: Top 23%
Polyomavirus and related diseases
1.05
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.